ED-Home Pilot Study

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT03864341
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
40
1
1
10.5
3.8

Study Details

Study Description

Brief Summary

This is a single-arm pilot study to test the feasibility of homelessness prevention and substance use interventions to be delivered to at-risk patients in the Bellevue Hospital emergency department (ED). ED patients (n=40) found eligible for the study will complete a baseline assessment and receive referrals to appropriate services, with a final six-month follow-up assessment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Referral to homelessness prevention services
  • Behavioral: Substance use services
  • Behavioral: Follow-up
N/A

Detailed Description

ED patients found eligible for the study will complete a baseline survey and receive one-time, in person services at the time of the baseline/enrollment ED visit including referrals to homelessness prevention and substance use services, with a final six-month follow-up survey. Interim contacts at 7-10 days, 3 months, and 5 months will be used to assure intervention components were received and to confirm participant contact information.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
ED-Home: A Pilot Feasibility Study of a Homelessness Prevention Intervention for Substance Using Emergency Department Patients
Actual Study Start Date :
May 8, 2019
Actual Primary Completion Date :
Mar 23, 2020
Actual Study Completion Date :
Mar 23, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Homelessness Prevention Services

Behavioral: Referral to homelessness prevention services
Referral to Homebase homelessness prevention services offered by community-based organizations in NYC

Behavioral: Substance use services
Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital

Behavioral: Follow-up
Follow-up to assist participants in receiving homelessness prevention services

Outcome Measures

Primary Outcome Measures

  1. Percentage of Potential Participants Approached Who Were Eligible for the Study [Month 6]

  2. Percentage of Eligible Participants Who Agreed to Participate in the Study [Month 6]

  3. Number of Participants Who Received Referrals for Homelessness Prevention and/or Substance Use Services [Month 6]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Be a patient in the Bellevue Hospital Center ED.

  • Be ≥18 years old.

  • Screen positive for homelessness risk using a homelessness risk screening tool (HRST).

  • Screen positive for unhealthy alcohol or drug use.

  • Able to provide consent.

Exclusion Criteria:
  • Medically (e.g., critically ill) or psychiatrically unstable.

  • Unable to provide informed consent for other reason (e.g., cognitive deficit, profound intoxication).

  • Incarcerated or in police custody.

  • Unable to understand and speak English.

  • Lives outside NYC and/or cannot give a NYC ZIP code.

  • Already homeless (residing in a shelter or on the streets).

  • Does not have a telephone where can be reached for follow-up.

  • Has already received specialized peer navigator/addiction social worker services during current ED visit.

  • Has already participated in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Kelly Doran, MD, MHS, New York Langone Medical Center

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03864341
Other Study ID Numbers:
  • 18-02040
  • K23DA039179
First Posted:
Mar 6, 2019
Last Update Posted:
Aug 19, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Homelessness Prevention Services
Arm/Group Description Referral to homelessness prevention services: Referral to Homebase homelessness prevention services offered by community-based organizations in NYC Substance use services: Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital Follow-up: Follow-up to assist participants in receiving homelessness prevention services
Period Title: Overall Study
STARTED 40
COMPLETED 39
NOT COMPLETED 1

Baseline Characteristics

Arm/Group Title Homelessness Prevention Services
Arm/Group Description Referral to homelessness prevention services: Referral to Homebase homelessness prevention services offered by community-based organizations in NYC Substance use services: Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital Follow-up: Follow-up to assist participants in receiving homelessness prevention services
Overall Participants 39
Age (years) [Mean (Full Range) ]
Mean (Full Range) [years]
44
Sex: Female, Male (Count of Participants)
Female
9
23.1%
Male
30
76.9%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
18
46.2%
Not Hispanic or Latino
21
53.8%
Unknown or Not Reported
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
1
2.6%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
19
48.7%
White
6
15.4%
More than one race
1
2.6%
Unknown or Not Reported
12
30.8%
Region of Enrollment (participants) [Number]
United States
39
100%

Outcome Measures

1. Primary Outcome
Title Percentage of Potential Participants Approached Who Were Eligible for the Study
Description
Time Frame Month 6

Outcome Measure Data

Analysis Population Description
This feasibility endpoint is related to the percentage of potential participants approached who were eligible to participate in the study -- since the number of eligible people is greater than those who were enrolled, the total number of "participants" analyzed is greater than what is listed in the participant flow.
Arm/Group Title Homelessness Prevention Services
Arm/Group Description Referral to homelessness prevention services: Referral to Homebase homelessness prevention services offered by community-based organizations in NYC Substance use services: Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital Follow-up: Follow-up to assist participants in receiving homelessness prevention services
Measure Participants 2183
Number [Percentage of Participants]
2.34
6%
2. Primary Outcome
Title Percentage of Eligible Participants Who Agreed to Participate in the Study
Description
Time Frame Month 6

Outcome Measure Data

Analysis Population Description
This feasibility endpoint is related to the percentage of eligible people who agreed to participate in the study -- since the number of eligible people is greater than those who were enrolled, the total number of "participants" analyzed is greater than what is listed in the participant flow.
Arm/Group Title Homelessness Prevention Services
Arm/Group Description Referral to homelessness prevention services: Referral to Homebase homelessness prevention services offered by community-based organizations in NYC Substance use services: Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital Follow-up: Follow-up to assist participants in receiving homelessness prevention services
Measure Participants 51
Number [Percentage of Participants]
78.43
201.1%
3. Primary Outcome
Title Number of Participants Who Received Referrals for Homelessness Prevention and/or Substance Use Services
Description
Time Frame Month 6

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Homelessness Prevention Services
Arm/Group Description Referral to homelessness prevention services: Referral to Homebase homelessness prevention services offered by community-based organizations in NYC Substance use services: Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital Follow-up: Follow-up to assist participants in receiving homelessness prevention services
Measure Participants 39
Count of Participants [Participants]
39
100%

Adverse Events

Time Frame 6 months
Adverse Event Reporting Description
Arm/Group Title Homelessness Prevention Services
Arm/Group Description Referral to homelessness prevention services: Referral to Homebase homelessness prevention services offered by community-based organizations in NYC Substance use services: Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital Follow-up: Follow-up to assist participants in receiving homelessness prevention services
All Cause Mortality
Homelessness Prevention Services
Affected / at Risk (%) # Events
Total 0/40 (0%)
Serious Adverse Events
Homelessness Prevention Services
Affected / at Risk (%) # Events
Total 0/40 (0%)
Other (Not Including Serious) Adverse Events
Homelessness Prevention Services
Affected / at Risk (%) # Events
Total 0/40 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Kelly Doran, MD, MHS
Organization NYU Langone Health
Phone (212) 263-5850
Email Kelly.doran@nyulangone.org
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03864341
Other Study ID Numbers:
  • 18-02040
  • K23DA039179
First Posted:
Mar 6, 2019
Last Update Posted:
Aug 19, 2022
Last Verified:
Jul 1, 2022